Lung Kee (Bermuda) Holdings Limited - 0255.HK

0255.HK Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
0255.HK	1.7	-4	12.1	-1.6	-9.8	-4	-69.1	-53.3	-42.9	15.4
S&P 500	0.6	1.5	2.6	4.0	9.4	25.5	38.0	83.2	195.0	34364.2

Compare 0255.HK with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	0255.HK
name	Lung Kee (Bermuda) Holdings Limited
price	1.2
changes percentage	1.6949
change	0.02
day low	1.2
day high	1.2
year high	1.45
year low	1.05
market cap	758012400
price avg 50	1.1254
price avg 200	1.2079
exchange	HKSE
volume	672000
avg volume	54541
open	1.2
previous close	1.18
eps	-0.1
pe	-12
earnings announcement	2025-05-27T19:00:00.000+0000
shares outstanding	631677000
timestamp	2025-01-23 03:26:51

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 41.3%

Overall Quarterly Financial Health: 57.0%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	1449340000	1601433000	-9.50
gross profit	263905000	397999000	-33.69
gross profit ratio	0.18	0.25	-26.73
research and development expenses	0	0	NaN
operating expenses	393438000	394126000	-0.17
interest income	8370000	12300000	-31.95
interest expense	406000	363000	11.85
ebitda	56871000	180738000	-68.53
ebitdaratio	0.04	0.1	-61.35
operating income	-124067000	3873000	-3303.38
operating income ratio	-0.09	0.0	-3639.54
net income	-72431000	15814000	-558.02
net income ratio	-0.05	0.01	-606.08
eps	-0.11	0.03	-540.00

Overall Score of Annual Income Statement

0.29 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 1,449 million in 2023 from 1,601 million in 2022 representing a change of -9.5%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 264 million in 2023 from 398 million in 2022 representing a change of -33.69%. This indicates a sales profitability decline, which is a negative sign for the company.

  Operating Income: Operating income decreased to -124 million in 2023 from 4 million in 2022 representing a change of -3303.38%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to -72 million in 2023 from 16 million in 2022 representing a change of -558.02%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to -0.11 in 2023 from -0.11 in 2022 representing a change of -540.0%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• 📈 Positive Indicators

  Operating Expenses: Operating Expenses decreased to 393 million in 2023 from 394 million in 2022 representing a change of -0.17%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 57 million in 2023 from 181 million in 2022 representing a change of -68.53%. The increase in EBITDA indicates improved operational efficiency and profitability.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
revenue	785212000	740417000	6.05
gross profit	441024000	114844000	284.02
gross profit ratio	0.56	0.16	262.11
research and development expenses	0	0	NaN
operating expenses	218083000	189144000	15.30
interest income	4578000	4196000	9.10
interest expense	129000	176000	-26.70
ebitda	55825000	23455000	138.01
ebitdaratio	0.07	0.01	424.25
operating income	222941000	-74300000	400.06
operating income ratio	0.28	-0.1	382.94
net income	-23915000	-40925000	41.56
net income ratio	-0.03	-0.06	44.90
eps	-0.04	-0.06	41.51

Overall Score of Quarterly Income Statement

0.71 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 785 million in 2024Q2 from 740 million in 2023Q4 representing a change of 6.05%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 441 million in 2024Q2 from 115 million in 2023Q4 representing a change of 284.02%. This indicates a sales profitability growth, which is a positive sign for the company.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 56 million in 2024Q2 from 23 million in 2023Q4 representing a change of 138.01%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 223 million in 2024Q2 from -74 million in 2023Q4 representing a change of 400.06%. The increase in operating income indicates better operational performance and increased profitability.

  Earnings per Share (EPS): EPS increased to -0.04 in 2024Q2 from -0.04 in 2023Q4 representing a change of 41.51%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 218 million in 2024Q2 from 189 million in 2023Q4 representing a change of 15.3%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  Net Income: Net income decreased to -24 million in 2024Q2 from -41 million in 2023Q4 representing a change of 41.56%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	2092985000	2301477000	-9.06
total liabilities	294223000	314896000	-6.57
total equity	1798762000	1986581000	-9.45
cash and cash equivalents	428758000	536643000	-20.10
short term investments	0	51369000	-100.00
long term investments	166500000	175000000	-4.86
total current assets	1136446000	1294068000	-12.18
total non current assets	956539000	1007408999	-5.05
total current liabilities	193305000	197706000	-2.23
total non current liabilities	100918000	117190000	-13.89
common stock	63168000	63168000	0.00
retained earnings	1073671000	1210585000	-11.31
total debt	6565000	9560000	-31.33

Overall Score of Annual Balance Sheet

0.33 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 2,093 million in 2023 from 2,301 million in 2022 representing a change of -9.06%. Suggesting a decrease in asset holdings.

  Total Equity: Total Equity decreased to 1,799 million in 2023 from 1,987 million in 2022 representing a change of -9.45%. This indicates a decrease in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 429 million in 2023 from 537 million in 2022 representing a change of -20.1%. This indicates a decrease in available liquid assets.

  Short Term Investments: Short Term Investments decreased to 0 million in 2023 from 51 million in 2022 representing a change of -100.0%. This indicates a decrease in short-term investment holdings.

  Total Current Assets: Total Current Assets decreased to 1,136 million in 2023 from 1,294 million in 2022 representing a change of -12.18%. This indicates a worsen liquidity position.

  Retained Earnings: Retained Earnings decreased to 1,074 million in 2023 from 1,211 million in 2022 representing a change of -11.31%. This indicates an accumulated losses.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 294 million in 2023 from 315 million in 2022 representing a change of -6.57%. This indicates a decrease in overall liabilities.

  Total Current Liabilities: Total Current Liabilities decreased to 193 million in 2023 from 198 million in 2022 representing a change of -2.23%. This indicates a lower short-term debt burden.

  Total Debt: Total Debt decreased to 7 million in 2023 from 10 million in 2022 representing a change of -31.33%. This indicates a reduction in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
total assets	1997841000	2092985000	-4.55
total liabilities	293963000	294223000	-0.09
total equity	1703878000	1798762000	-5.27
cash and cash equivalents	470541000	428758000	9.75
short term investments	7223000	8474000	-14.76
long term investments	161400000	166500000	-3.06
total current assets	1132047000	1136446000	-0.39
total non current assets	865794000	956539000	-9.49
total current liabilities	198403000	193305000	2.64
total non current liabilities	95560000	100918000	-5.31
common stock	63168000	63168000	0.00
retained earnings	1353007000	1073671000	26.02
total debt	4468000	6565000	-31.94

Overall Score of Quarterly Balance Sheet

0.44 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 1,998 million in 2024Q2 from 2,093 million in 2023Q4 representing a change of -4.55%. Suggesting a decrease in asset holdings.

  Total Equity: Total Equity decreased to 1,704 million in 2024Q2 from 1,799 million in 2023Q4 representing a change of -5.27%. This indicates a decrease in shareholders' equity.

  Short Term Investments: Short Term Investments decreased to 7 million in 2024Q2 from 8 million in 2023Q4 representing a change of -14.76%. This indicates a decrease in short-term investment holdings.

  Total Current Assets: Total Current Assets decreased to 1,132 million in 2024Q2 from 1,136 million in 2023Q4 representing a change of -0.39%. This indicates a worsen liquidity position.

  Total Current Liabilities: Total Current Liabilities increased to 198 million in 2024Q2 from 193 million in 2023Q4 representing a change of 2.64%. This indicates a higher short-term debt burden.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 294 million in 2024Q2 from 294 million in 2023Q4 representing a change of -0.09%. This indicates a decrease in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 471 million in 2024Q2 from 429 million in 2023Q4 representing a change of 9.75%. This indicates an increase in available liquid assets.

  Retained Earnings: Retained Earnings increased to 1,353 million in 2024Q2 from 1,074 million in 2023Q4 representing a change of 26.02%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 4 million in 2024Q2 from 7 million in 2023Q4 representing a change of -31.94%. This indicates a reduction in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	-107885000	-296943000	63.67
operating cash flow	77214000	89165000	-13.40
free cash flow	-35716000	-93175000	61.67
capital expenditure	-112930000	-182340000	38.07
depreciation and amortization	169079000	158705000	6.54
deferred income tax	0	0	NaN
stock based compensation	123000	0	NaN
accounts payables	-7494000	-96362000	92.22
inventory	63736000	-52692000	220.96
acquisitions net	0	12288000	-100.00
investments in property plant and equipment	-112930000	-182340000	38.07
net cash used for investing activites	-98072000	-170052000	42.33
debt repayment	-3984000	-4325000	7.88
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-69470000	-164211000	57.69
net cash used provided by financing activities	-73860000	-168899000	56.27
cash at end of period	428758000	536643000	-20.10
accounts receivables	-36410000	117576000	-130.97
cash at beginning of period	536643000	833586000	-35.62

Overall Score of Annual Cashflow Statement

0.62 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to -108 million in 2023 from -297 million in 2022 representing a change of 63.67%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Free Cash Flow: Free Cash Flow increased to -36 million in 2023 from -93 million in 2022 representing a change of 61.67%. This indicates an increase in cash generated after accounting for capital expenditures.

  Accounts Payables: The absolute value of Accounts Payables decreased to 7 million in 2023 from 96 million in 2022 representing a change of 92.22%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to -36 million in 2023 from 118 million in 2022 representing a change of -130.97%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

  Dividends Paid: Dividends Paid increased to -69 million in 2023 from -164 million in 2022 representing a change of 57.69%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 77 million in 2023 from 89 million in 2022 representing a change of -13.4%. This indicates that the company generated less cash from its core business operations.

  Capital Expenditure: Capital Expenditure increased to -113 million in 2023 from -182 million in 2022 representing a change of 38.07%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Stock-Based Compensation: Stock-Based Compensation increased to 0 million in 2023 from 0 million in 2022 representing a change of nan%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
operating cash flow	93119000	85604000	8.78
free cash flow	80017000	40097000	99.56
capital expenditure	-13102000	-45507000	71.21
depreciation and amortization	84921000	84341000	0.69
deferred income tax	0	-107979000	100.00
stock based compensation	0	123000	-100.00
accounts receivables	-8029999	-26202000	69.35
accounts payables	18585000	4913000	278.28
inventory	37268000	82115000	-54.61
acquisitions net	0	4537000	-100.00
investments in property plant and equipment	-13102000	-45507000	71.21
net cash used for investing activites	-11936000	-40970000	70.87
debt repayment	-1949000	0	NaN
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-31533000	-31614000	0.26
net cash used provided by financing activities	-33611000	-33717000	0.31
net change in cash	470541000	11718000	3915.54
cash at end of period	470541000	428758000	9.75
cash at beginning of period	0	417040000	-100.00

Overall Score of Quarterly Cashflow Statement

0.56 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 471 million in 2024Q2 from 12 million in 2023Q4 representing a change of 3915.54%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 93 million in 2024Q2 from 86 million in 2023Q4 representing a change of 8.78%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 80 million in 2024Q2 from 40 million in 2023Q4 representing a change of 99.56%. This indicates an increase in cash generated after accounting for capital expenditures.

  Stock-Based Compensation: Stock-Based Compensation decreased to 0 million in 2024Q2 from 0 million in 2023Q4 representing a change of -100.0%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Dividends Paid: Dividends Paid increased to -32 million in 2024Q2 from -32 million in 2023Q4 representing a change of 0.26%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• 📉 Negative Indicators

  Capital Expenditure: Capital Expenditure increased to -13 million in 2024Q2 from -46 million in 2023Q4 representing a change of 71.21%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Deferred Income Tax: Deferred Income Tax increased to 0 million in 2024Q2 from -108 million in 2023Q4 representing a change of 100.0%. This indicates that the company's tax liability for future periods has increased.

  Accounts Payables: The absolute value of Accounts Payables increased to 19 million in 2024Q2 from 5 million in 2023Q4 representing a change of 278.28%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables increased to -8 in 2024Q2 from -26 million in 2023Q4 representing a change of 69.35%. This suggests that the company is less capable of collecting payments from its customers.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	2.29	2.54	-9.50
net income per share	-0.11	0.03	-558.02
operating cash flow per share	0.12	0.14	-13.40
free cash flow per share	-0.06	-0.15	61.67
cash per share	0.68	0.93	-27.08
book value per share	2.85	3.14	-9.45
tangible book value per share	3.11	1.97	57.82
shareholders equity per share	2.85	3.14	-9.45
interest debt per share	0.01	0.02	-29.75
market cap	915932089.35	1705528718.1	-46.30
enterprise value	493739089.35	1178445718.1	-58.10
pe ratio	-12.65	107.85	-111.73
price to sales ratio	0.63	1.07	-40.66
pocfratio	11.86	19.13	-37.98
pfcf ratio	-25.64	-18.3	-40.10
pb ratio	0.51	0.86	-40.69
ptb ratio	0.51	0.86	-40.69
ev to sales	0.34	0.74	-53.71
enterprise value over ebitda	8.68	6.52	33.15
ev to operating cash flow	6.39	13.22	-51.62
ev to free cash flow	-13.82	-12.65	-9.30
earnings yield	-0.08	0.01	-952.86
free cash flow yield	-0.04	-0.05	28.62
debt to equity	0.0	0.0	-24.16
debt to assets	0.0	0.0	-24.49
net debt to ebitda	-7.42	-2.92	-154.56
current ratio	5.88	6.55	-10.18
interest coverage	-305.58	10.67	-2964.11
income quality	-1.07	5.64	-118.91
dividend yield	0.08	0.1	-21.22
payout ratio	-0.96	10.38	-109.24
sales general and administrative to revenue	0.0	0.01	-58.01
research and ddevelopement to revenue	0	0	NaN
intangibles to total assets	-0.08	0.32	-124.70
capex to operating cash flow	1.46	2.04	-28.48
capex to revenue	0.08	0.11	-31.57
capex to depreciation	0.67	1.15	-41.87
stock based compensation to revenue	0.0	0	NaN
graham number	2.71	1.33	103.65
roic	-0.04	0.0	-3226.50
return on tangible assets	-0.03	0.01	-416.26
graham net net	0.75	1.03	-27.30
working capital	943141000	1096362000	-13.98
tangible asset value	1965262000	1245263001	57.82
net current asset value	842223000	979172000	-13.99
invested capital	1523258000	2657580999	-42.68
average receivables	95823500	127839000	-25.04
average payables	85814000	192754000	-55.48
average inventory	568717500	605599500	-6.09
days sales outstanding	24.08	21.89	10.04
days payables outstanding	11.03	41.19	-73.22
days of inventory on hand	163.35	184.08	-11.26
receivables turnover	15.16	16.68	-9.12
payables turnover	33.09	8.86	273.47
inventory turnover	2.23	1.98	12.69
roe	-0.04	0.01	-605.84
capex per share	0.18	0.29	-38.07

• Negative

  ROE: Return on Equity (ROE) decreased to -0.04 on 2023-12-31 from 0.01 on 2022-12-31, representing a change of -605.84%. Suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to -12.65 on 2023-12-31 from 107.85 on 2022-12-31, representing a change of -111.73%. Indicating a decrease in the relative valuation of the company's stock.

  Current Ratio: Current Ratio decreased to 5.88 on 2023-12-31 from 6.55 on 2022-12-31, representing a change of -10.18%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Positive

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.00 on 2023-12-31 from 0.00 on 2022-12-31, representing a change of -24.16%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-06-30 Q2	2023-12-31 Q4	Q/Q change %
0255.HK
calendar year	2024	2023	NaN
revenue per share	1.24	1.17	6.16
net income per share	-0.04	-0.06	41.50
operating cash flow per share	0.15	0.14	8.90
free cash flow per share	0.13	0.06	99.77
cash per share	0.76	0.69	9.39
book value per share	2.7	2.85	-5.17
tangible book value per share	2.7	3.22	-16.07
shareholders equity per share	2.7	2.85	-5.17
interest debt per share	0.01	0.01	-31.73
market cap	757203165.6	915932089.35	-17.33
enterprise value	291130165.6	493739089.35	-41.04
pe ratio	-7.92	-5.6	-41.47
price to sales ratio	0.96	1.24	-22.05
pocfratio	8.13	10.7	-24.00
pfcf ratio	9.46	22.84	-58.57
pb ratio	0.44	0.51	-12.73
ptb ratio	0.44	0.51	-12.73
ev to sales	0.37	0.67	-44.40
enterprise value over ebitda	5.22	21.05	-75.23
ev to operating cash flow	3.13	5.77	-45.79
ev to free cash flow	3.64	12.31	-70.45
earnings yield	-0.03	-0.04	29.31
free cash flow yield	0.11	0.04	141.39
debt to equity	0.0	0.0	-28.15
debt to assets	0.0	0.0	-28.70
net debt to ebitda	-8.35	-18.0	53.62
current ratio	5.71	5.88	-2.95
interest coverage	1728.22	-422.16	509.38
income quality	-3.89	-2.09	-86.15
dividend yield	0.04	0.03	20.65
payout ratio	-1.32	-0.77	-70.69
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0	0	NaN
intangibles to total assets	0	-0.11	100.00
capex to operating cash flow	0.14	0.53	-73.53
capex to revenue	0.02	0.06	-72.85
capex to depreciation	0.15	0.54	-71.41
stock based compensation to revenue	0	0.0	-100.00
graham number	1.52	2.04	-25.52
roic	0.11	-0.03	507.48
return on tangible assets	-0.01	-0.02	31.95
graham net net	0.81	0.76	6.03
working capital	933644000	943141000	-1.01
tangible asset value	1703878000	2032264000	-16.16
net current asset value	838084000	842223000	-0.49
invested capital	1582516000	1456256000	8.67
average receivables	None	None	NaN
average payables	None	None	NaN
average inventory	None	None	NaN
days sales outstanding	12.91	11.62	11.03
days payables outstanding	9.35	18.43	-49.26
days of inventory on hand	125.59	76.32	64.55
receivables turnover	6.97	7.74	-9.93
payables turnover	9.63	4.88	97.08
inventory turnover	0.72	1.18	-39.23
roe	-0.01	-0.02	38.31
capex per share	0.02	0.07	-71.18

• Negative

  ROE: Return on Equity (ROE) increased to -0.01 on 2024-06-30 Q2 from -0.02 on 2023-12-31 Q4, representing a change of 38.31%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to -7.92 on 2024-06-30 Q2 from -5.60 on 2023-12-31 Q4, representing a change of -41.47%. Indicating a decrease in the relative valuation of the company's stock.

  Current Ratio: Current Ratio decreased to 5.71 on 2024-06-30 Q2 from 5.88 on 2023-12-31 Q4, representing a change of -2.95%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Positive

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.00 on 2024-06-30 Q2 from 0.00 on 2023-12-31 Q4, representing a change of -28.15%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Positive Sentiment: Discounted Cash Flow value is 2.02 which is higher than current price 1.2, indicates the company may be undervalued.